116 related articles for article (PubMed ID: 9279773)
21. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
[TBL] [Abstract][Full Text] [Related]
22. Age-related effect of ritanserin on the sleep-waking phases in rats.
Kirov R; Moyanova S
Int J Neurosci; 1998 Apr; 93(3-4):265-78. PubMed ID: 9639244
[TBL] [Abstract][Full Text] [Related]
23. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
[TBL] [Abstract][Full Text] [Related]
24. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C
Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536
[TBL] [Abstract][Full Text] [Related]
25. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
van Laar M; Volkerts E; Verbaten M
Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
[TBL] [Abstract][Full Text] [Related]
26. Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors.
Consolo S; Arnaboldi S; Ramponi S; Nannini L; Ladinsky H; Baldi G
J Pharmacol Exp Ther; 1996 May; 277(2):823-30. PubMed ID: 8627564
[TBL] [Abstract][Full Text] [Related]
27. The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes.
Harel-Dupas C; Cloëz I; Fillion G
J Neurochem; 1991 Jan; 56(1):221-7. PubMed ID: 1824781
[TBL] [Abstract][Full Text] [Related]
28. Presynaptic modulation of acetylcholine, noradrenaline, and serotonin release in the hippocampus of aged rats with various levels of memory impairments.
Birthelmer A; Stemmelin J; Jackisch R; Cassel JC
Brain Res Bull; 2003 May; 60(3):283-96. PubMed ID: 12754090
[TBL] [Abstract][Full Text] [Related]
29. Effects of 5HT2 receptor antagonists on responses to potassium depolarization in rat isolated aorta.
Okoro EO; Marwood JF
Clin Exp Pharmacol Physiol; 1997 Jan; 24(1):34-9. PubMed ID: 9043803
[TBL] [Abstract][Full Text] [Related]
30. Blockade of 5-hydroxytryptamine (serotonin)-2 receptors alters interleukin-1-induced changes in rat sleep.
Imeri L; Mancia M; Opp MR
Neuroscience; 1999; 92(2):745-9. PubMed ID: 10408622
[TBL] [Abstract][Full Text] [Related]
31. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
32. Effect of ritanserin and leuprolide alone and combined on marble-burying behavior of mice.
Gaikwad U; Parle M; Kumar A; Gaikwad D
Acta Pol Pharm; 2010; 67(5):523-7. PubMed ID: 20873421
[TBL] [Abstract][Full Text] [Related]
33. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.
Pehek EA
Synapse; 1996 Sep; 24(1):12-8. PubMed ID: 9046072
[TBL] [Abstract][Full Text] [Related]
34. Phenylethylamine-induced release of noradrenaline fails to stimulate alpha 1-adrenoceptors modulating [3H]-acetylcholine release in rat atria, but activates alpha 2-adrenoceptors modulating [3H]-serotonin release in the hippocampus.
Benkirane S; Arbilla S; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):149-55. PubMed ID: 3024030
[TBL] [Abstract][Full Text] [Related]
35. Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Río J
Brain Res; 1996 Mar; 712(2):274-80. PubMed ID: 8814902
[TBL] [Abstract][Full Text] [Related]
36. Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice.
Yamada J; Sugimoto Y; Ohkura M; Inoue K
Biol Pharm Bull; 2001 Oct; 24(10):1195-7. PubMed ID: 11642332
[TBL] [Abstract][Full Text] [Related]
37. Peripherally administered serotonin induces hyperglucagonemia in mice.
Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Takeuchi N; Horisaka K
Life Sci; 1993; 52(23):1845-9. PubMed ID: 8502121
[TBL] [Abstract][Full Text] [Related]
38. Serotonin receptor antagonists increase fast ripple activity in rats treated with kainic acid.
García-Barba C; Medina-Ceja L
Brain Res Bull; 2016 Mar; 121():59-67. PubMed ID: 26772625
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein.
Wang HY; Yue TL; Feuerstein G; Friedman E
J Neurochem; 1994 Nov; 63(5):1720-5. PubMed ID: 7931326
[TBL] [Abstract][Full Text] [Related]
40. Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin.
Devaud LL; Hollingsworth EB; Cooper BR
J Neurochem; 1992 Oct; 59(4):1459-66. PubMed ID: 1402896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
